Calcium folinate pentahydrate
Myeloid Leukemia Associated With Down Syndrome
National Cancer Institute (NCI)Small moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
10 Active assets in the Myeloid Leukemia Associated With Down Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cytosin-Arabinosid National Cancer Institute (NCI) | Phase 3 | BB |
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT) Children's Oncology Group | Phase 3 | B |
Mitoxantrone Children's Oncology Group | Phase 3 | B |
THIOGUANINE ANHYDROUS Children's Oncology Group | Phase 3 | B |
ETOPOSIDE Children's Oncology Group | Phase 3 | B |
View all 10 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →